The Asia Pacific Precision Diagnostics Market would witness market growth of 18.7% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Precision Diagnostics Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,648.8 million by 2031. The Japan market is showcasing a CAGR of 18.1% during (2024 - 2031). Additionally, The India market would register a CAGR of 19.6% during (2024 - 2031).
Precision diagnostics are vital for rapidly and accurately detecting infectious agents, characterization of antimicrobial resistance, and epidemiological surveillance. PCR and sequencing-based tests for viral, bacterial, and fungal infections (e.g., COVID-19 diagnostics). Identifying genetic markers of resistance to guide antibiotic therapy.
Additionally, they assess genetic variants affecting drug metabolism and response (e.g., CYP2D6, CYP2C19), identify genetic predispositions to adverse drug reactions and drug-induced toxicities, and target cancer therapies based on tumor genetic profiling and drug sensitivity testing.
Diseases such as cancer, diabetes, respiratory illnesses, and cardiovascular conditions are prevalent in Australia's aging population, driving the need for precise and early diagnostics. According to the Government of Australia, among people of all ages, an estimated 15.4 million (61%) were living with at least one of the selected long-term health conditions in 2022. This ranged from 28% of people aged 0–14 to 94% aged 85 and over. Precision diagnostics are crucial in early disease detection, enabling timely interventions and personalized treatment plans tailored to individual patient profiles.
Free Valuable Insights: The Global Precision Diagnostics Market is Predict to reach USD 55.03 Billion by 2031, at a CAGR of 18.0%
Based on End-use, the market is segmented into Clinical Laboratories, Hospitals, and Others. Based on Type, the market is segmented into Genetic Tests, Esoteric Tests, Direct to Consumer Tests, and Others. Based on Application, the market is segmented into Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
By End-use
By Type
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 